Researchers at the Francis Crick Institute have identified structural changes in COVID-19 variants which provide clues to how the virus evolved to have greater levels of infectivity.
Mar 4, 2022
0
40
Scientists at the Max Planck Institute for Medical Research in Heidelberg and their collaborators at the Max Planck Bristol Center for Minimal Biology at the University of Bristol have developed a new approach to study SARS-CoV-2. ...
Feb 21, 2022
0
436
Antibodies generated by COVID-19 vaccines are more suited to recognizing viral variants than antibodies that arise from natural infection, according to a study by researchers at Stanford Medicine.
Feb 17, 2022
1
221
Preclinical models that recapitulate aspects of human airway disease are essential for the advancement of novel therapeutics and vaccines. In the current study published in the journal mBIO, researchers at Baylor College ...
Feb 15, 2022
0
131
Researchers have identified a powerful combination of antivirals to treat COVID-19. Combining the drug brequniar with remdesivir or molnupiravir—both approved by the U.S. Food and Drug Administration for emergency use—inhibited ...
Feb 7, 2022
0
454
The immune system develops a high-quality antibody response after three encounters with the coronavirus spike protein. These antibodies are also capable of neutralizing omicron efficiently. This applies to people who are ...
Feb 3, 2022
0
374
Many questions about how exposure to SARS-CoV-2 by infection or immunization might result in long-term protective immunity remain unanswered. Onur Boyman, head of the Department of Immunology, and his research team at the ...
Feb 2, 2022
0
124
A new study from MIT suggests that the dozens of mutations in the spike protein of the omicron variant help it to evade all four of the classes of antibodies that can target the SARS-CoV-2 virus that causes COVID-19.
Feb 1, 2022
0
182
Research led by scientists at the MRC-University of Glasgow Centre for Virus Research and the University of Oxford, in collaboration with UKHSA and Brighton NHS have revealed new insights into transmissibility of variants ...
Jan 31, 2022
0
64
A team of researchers at genomics and biotechnology company 23andMe have found that people with a certain genetic locus are 11% more likely to lose the ability to smell or taste due to a COVID-19 infection. In their paper ...
